Info
Insider Ownership

Insider Trading & Ownership of James B. Breitmeyer

Summary: The estimated net worth of James B. Breitmeyer is at least $325K dollars as of February 15, 2024. James B. Breitmeyer is the Chief Executive Officer, Director of Oncternal Therapeutics, Inc. and owns shares of Oncternal Therapeutics, Inc. stock worth about $325K.
Signature: /s/Chase C. Leavitt, Attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when James B. Breitmeyer files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of James B. Breitmeyer

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ONCT	Oncternal Therapeutics, Inc.	Chief Executive Officer, Director	$325K			Feb 14, 2024
OTIC	OTONOMY, INC.	Director				Jun 21, 2022
ZGNX	ZOGENIX, INC.	Director				Mar 7, 2022

Insider Transactions Reported by James B. Breitmeyer:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.